Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-06-29
2009-10-20
Pak, Michael (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07605119
ABSTRACT:
The present invention provides methods and compositions for enhancing memory in animals, including humans by the administration of an effective amount of an atypical form of protein kinase C such as protein kinase M zeta (PKMζ) or protein kinase C iota/lambda.
REFERENCES:
patent: 2004/0247584 (2004-12-01), Sacktor
patent: 2005/0070565 (2005-03-01), Arnsten et al.
Barad et al. Society for Neuroscience Abstracts 24(1-2): p. 328, abstract No. 131.14 (1998).
Thiam, et al., “Direct Evidence of Cytoplasmic Delivery of PKC-α, -ε and -ξ Pseudosubstrate lipopeptides: Study of Their Implication in the Induction of Apoptosis”,FEBS Letters, vol. 459, pp. 285-290, (1999).
Pak Michael
Scully , Scott, Murphy & Presser, P.C.
The Research Foundation of State University of New York
LandOfFree
Memory enhancing protein method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Memory enhancing protein method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memory enhancing protein method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4109649